Terry B. Strom: not just a pillar but a foundation.

Front Transplant

Weill Cornell Medical Center, NewYork-Presbyterian, New York, NY, United States.

Published: December 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11647024PMC
http://dx.doi.org/10.3389/frtra.2024.1519975DOI Listing

Publication Analysis

Top Keywords

terry strom
4
strom pillar
4
pillar foundation
4
terry
1
pillar
1
foundation
1

Similar Publications

Checkpoint Receptor TIGIT Expressed on Tim-1 B Cells Regulates Tissue Inflammation.

Cell Rep

July 2020

Evergrande Center for Immunologic Diseases and Ann Romney Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address:

Tim-1, a phosphatidylserine receptor expressed on B cells, induces interleukin 10 (IL-10) production by sensing apoptotic cells. Here we show that mice with B cell-specific Tim-1 deletion develop tissue inflammation in multiple organs including spontaneous paralysis with inflammation in the central nervous system (CNS). Transcriptomic analysis demonstrates that besides IL-10, Tim-1 B cells also differentially express a number of co-inhibitory checkpoint receptors including TIGIT.

View Article and Find Full Text PDF

Background: Acute T-cell mediated rejection (TCMR) is usually indicated by alteration in serum-creatinine measurements when considerable transplant damage has already occurred. There is, therefore, a need for non-invasive early detection of immune signals that would precede the onset of rejection, prior to transplant damage.

Methods: We examined the RT-qPCR expression of 22 literature-based genes in peripheral blood samples from 248 patients in the Kidney Allograft Immune Biomarkers of Rejection Episodes (KALIBRE) study.

View Article and Find Full Text PDF
Article Synopsis
  • Hematopoietic stem/progenitor cells (HSPCs) have the unique ability to self-renew and differentiate into various cell types, adapting to their environment.
  • In a study using a peritonitis animal model induced by zymosan, researchers examined how these BM-derived HSPCs interact with innate lymphoid cells (ILCs) during inflammation.
  • Results indicate that low doses of zymosan lead to ILCs that rely on HSPCs for differentiation, while high doses of zymosan promote ILC emergence independently of HSPCs due to stronger inflammatory signals.
View Article and Find Full Text PDF

Objective: To determine the safety and pharmacokinetics of alpha-1 antitrypsin (AAT) in adults and children.

Research Design And Methods: Short-term AAT treatment restores euglycemia in the non-obese mouse model of type 1 diabetes. A phase I multicenter study in 16 subjects with new-onset type 1 diabetes studied the safety and pharmacokinetics of Aralast NP (AAT).

View Article and Find Full Text PDF

Phosphatidylinositol-3-kinases (PI3K) γ and δ are preferentially enriched in leukocytes, and defects in these signaling pathways have been shown to impair T cell activation. The effects of PI3Kγ and PI3Kδ on alloimmunity remain underexplored. Here, we show that both PI3Kγ and PI3Kδ mice receiving heart allografts have suppression of alloreactive T effector cells and delayed acute rejection.

View Article and Find Full Text PDF